ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO). The meeting will feature a number of presentations highlighting […]
Rick Carlson, CEO of SharpSpring, Named “Geek of the Week” on Cloud Wedge
UF startup SharpSpring is a rapidly growing organization that is globally known for providing services such as marketing automation on a cloud-based platform, specifically the Software-as-a-Service (SaaS) platform. They supply quite a number of businesses around the world with their services, including dynamic contracts monthly, to ensure growth and expansion in the digital marketing age. […]
Virtual Humans Boost Mental Health Recovery
Humans are social creatures, but some things are just hard to talk about. For many people, mental health is one of those things. But what if you can’t talk about something where the leading treatment is talk therapy? Maybe try speaking to someone who’s not human. Benjamin Lok, a professor in the computer and information […]
AGTC to Present at Upcoming Conferences
UF startup Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that management will be participating in the following conferences: 14th Annual Wells Fargo Securities Healthcare Conference – Boston (September 4-5, 2019) 21st Annual H.C. Wainwright Global Investment Conference […]
OxThera Receives Positive Decision From EMA on Paediatric Investigational Plan (PIP) for Treatment of Primary Hyperoxaluria With Oxalobacter Formigenes
UF startup OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announced that, based on a positive opinion from the Paediatric Committee (PDCO), the European Medicines Agency (EMA) has agreed to the proposed PIP for Oxalobacter formigenes in the treatment of primary hyperoxaluria. “We are pleased to […]
Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium
UF startup Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it will be presenting a talk titled “Lantibiotics, a Novel Class of Antibiotics in the Pharmacopeia,” which will be part of a session dedicated to novel antimicrobial developments to counter multidrug-resistant bacterial infections […]
MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers
UF startup ViewRay Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with localized prostate cancer. This robust study of clinician and patient-reported outcomes […]
Ology Bioservices, Inc. Will Receive $9 Million of Funding to Support Manufacturing of Nipah Virus Vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) will provide $43.6 million to advance the development and manufacture of the rVSV-Nipah vaccine candidate against the Nipah virus. UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), will receive $9M to support the manufacturing and stockpiling of the rVSV-Nipah vaccine. The Nipah virus, […]
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.
Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), to manufacture a novel universal influenza vaccine. The vaccine, based on technology licensed from the prestigious University of Oxford in the U.K., has shown promising results in a preclinical study […]
Morphogenesis, Inc. Is Testing Cancer Vaccine
Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology that could help people who already have cancer fight it off. Six patients with stage three and stage four melanoma started the trial in November 2018. Morphogenesis, Inc., is working with specialists at Moffitt […]